Literature DB >> 19888571

On a biophysical and mathematical model of Pgp-mediated multidrug resistance: understanding the "space-time" dimension of MDR.

Vasiliki Panagiotopoulou1, Giles Richardson, Oliver E Jensen, Cyril Rauch.   

Abstract

Multidrug resistance (MDR) is explained by drug transporters with a drug-handling activity. Despite much work, MDR remains multifaceted, and several conditions are required to generate drug resistance. The drug pumping was conceptually described using a kinetic, i.e., temporal, approach. The re-emergence of physical biology has allowed us to take into account new parameters focusing on the notion of space. This, in turn, has given us important clues regarding the process whereby drug and transporter interact. We will demonstrate that the likelihood of drug-transporter meeting (i.e., the affinity) and thus interaction are also driven by the mechanical interaction between drug molecular weight (MW) and the membrane mechanical properties. This should allow us to mechanically control drug delivery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19888571     DOI: 10.1007/s00249-009-0555-5

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  69 in total

1.  Endocytosis switch controlled by transmembrane osmotic pressure and phospholipid number asymmetry.

Authors:  C Rauch; E Farge
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

Review 2.  Current trends in lead discovery: are we looking for the appropriate properties?

Authors:  Tudor I Oprea
Journal:  Mol Divers       Date:  2002       Impact factor: 2.943

Review 3.  Role of transport proteins in drug discovery and development: a pharmaceutical perspective.

Authors:  A Ayrton; P Morgan
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

4.  Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein.

Authors:  A B Shapiro; V Ling
Journal:  Eur J Biochem       Date:  1997-11-15

5.  Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.

Authors:  M J Borgnia; G D Eytan; Y G Assaraf
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

6.  Drug binding sites on P-glycoprotein are altered by ATP binding prior to nucleotide hydrolysis.

Authors:  C Martin; G Berridge; P Mistry; C Higgins; P Charlton; R Callaghan
Journal:  Biochemistry       Date:  2000-10-03       Impact factor: 3.162

Review 7.  Mechanism of multidrug recognition by MDR1/ABCB1.

Authors:  Yasuhisa Kimura; Shin-ya Morita; Michinori Matsuo; Kazumitsu Ueda
Journal:  Cancer Sci       Date:  2007-06-30       Impact factor: 6.716

Review 8.  New insights into the drug binding, transport and lipid flippase activities of the p-glycoprotein multidrug transporter.

Authors:  Frances J Sharom; Miguel R Lugo; Paul D W Eckford
Journal:  J Bioenerg Biomembr       Date:  2005-12       Impact factor: 3.853

9.  Multi drug resistance-dependent "vacuum cleaner" functionality potentially driven by the interactions between endocytosis, drug size and Pgp-like transporters surface density.

Authors:  Cyril Rauch; Alain Pluen
Journal:  Eur Biophys J       Date:  2007-01-09       Impact factor: 2.095

Review 10.  New light on multidrug binding by an ATP-binding-cassette transporter.

Authors:  Richard A Shilling; Henrietta Venter; Saroj Velamakanni; Akanksha Bapna; Barbara Woebking; Sanjay Shahi; Hendrik W van Veen
Journal:  Trends Pharmacol Sci       Date:  2006-03-20       Impact factor: 14.819

View more
  4 in total

Review 1.  The dynamics of drug resistance: a mathematical perspective.

Authors:  Orit Lavi; Michael M Gottesman; Doron Levy
Journal:  Drug Resist Updat       Date:  2012-03-03       Impact factor: 18.500

2.  Proton dynamics in cancer.

Authors:  Veronica Huber; Angelo De Milito; Salvador Harguindey; Stephan J Reshkin; Miriam L Wahl; Cyril Rauch; Antonio Chiesi; Jacques Pouysségur; Robert A Gatenby; Licia Rivoltini; Stefano Fais
Journal:  J Transl Med       Date:  2010-06-15       Impact factor: 5.531

3.  Importance of the difference in surface pressures of the cell membrane in doxorubicin resistant cells that do not express Pgp and ABCG2.

Authors:  Charlotte Bell; Claire Hill; Christopher Burton; Adam Blanchard; Freya Shephard; Cyril Rauch
Journal:  Cell Biochem Biophys       Date:  2013-07       Impact factor: 2.194

4.  Proton pump inhibitors for the treatment of cancer in companion animals.

Authors:  Megan Walsh; Stefano Fais; Enrico Pierluigi Spugnini; Salvador Harguindey; Tareq Abu Izneid; Licia Scacco; Paula Williams; Cinzia Allegrucci; Cyril Rauch; Ziad Omran
Journal:  J Exp Clin Cancer Res       Date:  2015-09-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.